Medication Errors in New York Dialysis Centers: Proving Negligence

Medication Safety in Dialysis Centers

Dialysis centers provide life-sustaining treatment to patients with end-stage renal disease (ESRD). During each hemodialysis session — typically 3-4 hours, three times per week — patients receive multiple medications, including anticoagulants, anemia management drugs, and electrolyte supplements. The high-throughput nature of dialysis centers, combined with the use of high-alert medications, creates significant risk for medication errors.

New York has hundreds of dialysis centers operated by major chains (Fresenius Medical Care, DaVita, US Renal Care) as well as hospital-based and independent facilities. When medication errors occur in these settings, the consequences can be catastrophic — patients with ESRD are already in fragile health and have limited physiologic reserve to withstand additional injury.

[Link to: /medical-malpractice/medication-errors]

High-Alert Medications Used in Dialysis

Heparin

Heparin is administered during most hemodialysis sessions to prevent blood clotting in the dialysis circuit. Dialysis heparin errors include:

• Wrong concentration — Using a different concentration than programmed
• Wrong rate — Programming errors with heparin infusion pumps
• Bolus errors — Giving too much heparin as an initial bolus
• Failure to stop — Not discontinuing heparin at the end of the session, leading to post-dialysis bleeding
• Contraindicated heparin — Giving heparin to a patient with heparin-induced thrombocytopenia (HIT)

Erythropoiesis-Stimulating Agents (ESAs)

Medications like epoetin alfa (Epogen, Procrit) and darbepoetin alfa (Aranesp) are used to treat anemia in dialysis patients. Errors include:

• Wrong dose — Administering too much ESA, increasing the risk of cardiovascular events and thromboembolism
• Wrong patient — Giving one patient's ESA to another patient
• Missed doses — Failing to administer the prescribed ESA

IV Iron

Intravenous iron (iron sucrose, ferric gluconate, ferumoxytol) is administered to dialysis patients to treat iron deficiency. Errors include:

• Too-rapid infusion — Causing hypotension and anaphylactoid reactions
• Wrong product — Using a different iron formulation with different infusion rate requirements
• Allergy administration — Giving IV iron to a patient with a documented iron allergy

Electrolyte Supplements

• Potassium — Wrong dose or route, particularly dangerous in ESRD patients who cannot excrete potassium
• Calcium — Wrong concentration or rate, causing arrhythmias
• Phosphate binders — Wrong medication or dose

Vitamin D Analogues

IV vitamin D (paricalcitol, calcitriol) is administered to manage secondary hyperparathyroidism in dialysis patients. Errors include:

• Wrong dose — Causing hypercalcemia or hypocalcemia
• Wrong patient — Administering to the wrong dialysis chair

[Link to: /medical-malpractice/medication-errors/iv-infusion-pump]

How Dialysis Medication Errors Happen

Chair-to-Chair Confusion

Dialysis centers typically have multiple patients receiving treatment simultaneously in an open bay. Medications prepared for one patient may be administered to another due to:

• Failure to verify patient identity at the chairside
• Medications left on top of dialysis machines without patient labels
• Dialysis chair assignments changed without updating medication orders
• Barcode scanning not used or not available

Pre-Mixed Medication Errors

Many dialysis medications are pre-mixed by the pharmacy or manufacturer. Errors can occur when:

• The wrong concentration is stocked
• The label is misread
• The wrong medication is selected from the ADC

Protocol-Driven Errors

Dialysis centers use protocols for medication titration (e.g., heparin protocols, ESA dosing protocols). Errors occur when:

• The protocol is applied to the wrong patient
• The protocol is not followed correctly
• The protocol is outdated or inappropriate for the patient

Staffing and Time Pressure

Dialysis centers operate on tight schedules, with patients cycling through chairs every 4 hours. Staffing shortages and time pressure contribute to:

• Rushed medication preparation
• Skipping patient identification verification
• Failure to document medication administration
• Failure to monitor for adverse reactions

Standard of Care for Dialysis Medication Administration

CMS Conditions for Coverage

Dialysis centers certified by Medicare must comply with the CMS Conditions for Coverage (42 CFR Part 494), which require:

• Physician orders for all medications
• Pharmacy services to review medication orders
• Medication administration records
• Adverse event reporting

ISMP Guidelines

The ISMP recommends specific safety practices for dialysis centers:

• Barcode verification at the chairside
• Independent double checks for high-alert medications
• Standardized concentrations for all dialysis medications
• Patient identification using two identifiers at every medication administration

New York State Requirements

Under 10 NYCRR § 405 and PHL § 2805-j, dialysis centers in New York must implement patient safety programs. NYPORTS reporting is required for medication errors causing patient harm.

Proving Negligence in Dialysis Medication Cases

Medical Record Review

Key evidence includes:

• Dialysis flow sheets — Showing medications administered, vital signs, and treatment parameters
• Medication administration records (MAR)
• Physician orders — Including dialysis prescriptions and medication protocols
• Laboratory values — Including potassium, calcium, phosphorus, hemoglobin, and iron studies
• Incident reports — Their existence can be established
• ADC transaction logs — From the dialysis center's dispensing cabinet

Expert Testimony

Dialysis cases require specialized experts:

• A nephrologist to testify about the standard of care for dialysis medication management
• A dialysis nurse to testify about nursing standards in the dialysis setting
• A pharmacist to testify about pharmacy services and medication safety

Causation

In dialysis cases, causation can be complex because patients with ESRD often have multiple comorbidities. The defense may argue that the patient's underlying condition — not the medication error — caused the harm. We counter this with:

• Temporal relationship between the medication error and the adverse event
• Known pharmacological effects of the wrong medication or dose
• Exclusion of other causes through medical record review

Damages and Statute of Limitations

Damages

New York does not cap medical malpractice damages. Compensation may include:

• Medical expenses (past and future)
• Lost wages
• Pain and suffering
• Loss of consortium
• Wrongful death damages under EPTL § 5-4.1

Statute of Limitations

| Claim Type | Deadline | Legal Basis | |---|---|---| | Private dialysis center | 2.5 years | CPLR § 214-a | | Hospital-based dialysis (municipal) | 90 days Notice + 1 year 90 days | GML § 50-e, § 50-i | | Wrongful death | 2 years from death | EPTL § 5-4.1 |

Frequently Asked Questions

What medications are most commonly involved in dialysis errors?

The most common medications involved are heparin (wrong concentration, wrong rate, failure to discontinue), erythropoiesis-stimulating agents (wrong dose, wrong patient), IV iron (too-rapid infusion, wrong product), and electrolyte supplements (potassium, calcium).

How do dialysis medication errors most commonly occur?

The most common cause is "chair-to-chair confusion" — administering one patient's medication to another patient in the same dialysis bay. This typically results from failure to verify patient identity, unlabeled medications left on dialysis machines, or lack of barcode scanning.

Can I sue a dialysis center for a medication error?

Yes. Dialysis centers can be held liable for medication errors under New York medical malpractice law. Both the facility and individual healthcare providers (nephrologists, nurses, pharmacists) can be named as defendants.

What is the statute of limitations for a dialysis medication error in NY?

Generally 2.5 years under CPLR § 214-a for private dialysis centers. For hospital-based dialysis at municipal hospitals, a Notice of Claim must be filed within 90 days and the SOL is 1 year and 90 days.

What is heparin-induced thrombocytopenia (HIT)?

HIT is a serious immune-mediated reaction to heparin that causes paradoxical blood clotting and low platelet counts. Administering heparin to a patient with known HIT is a serious medication error that can cause life-threatening thrombosis.

This article is for informational purposes only and does not constitute legal advice. Prior results do not guarantee a similar outcome. No attorney-client relationship is created by reading this article or contacting MDLaw Firm.